Lexington, MA, United States of America

Samantha M Goodstal

This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Merck Patent Gmbh. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Samantha M Goodstal. Retrieved from https://idiyas.com/inventor/samantha-m-goodstal

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Cancer Treatment by Samantha M Goodstal

Introduction

Samantha M Goodstal is an accomplished inventor based in Lexington, MA (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of new therapeutic methods.

Latest Patents

Samantha holds 1 patent for her work titled "Methods for treating cancer using pyrimidine and pyridine compounds with BTK inhibitory activity." This invention provides methods of treating cancer using pyrimidine and pyridine compounds that act as inhibitors of Bruton's tyrosine kinase (BTK).

Career Highlights

Samantha is currently associated with Merck Patent GmbH, where she continues to advance her research in oncology. Her work has the potential to impact the lives of many patients suffering from cancer, showcasing her dedication to improving healthcare outcomes.

Collaborations

Throughout her career, Samantha has collaborated with notable colleagues, including Claude Gimmi-McKim and Bayard R Huck. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Samantha M Goodstal's contributions to cancer treatment through her patented methods highlight her role as a leading inventor in the field. Her work exemplifies the importance of innovation in addressing critical health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…